SCHEMBL715825

SCHEMBL715825

Cc1cc(C)c(-c2ccc3c(c2)-c2cc(-c4c(C)cc(C)cc4C)ccc2[CH]3)c(C)c1

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.33
MAPT P10636 2/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
TDP1 Q9NUW8 2/20 0.32
TP53 P04637 1/20 0.32
CYP3A4 P08684 1/20 0.32
TSHR P16473 1/20 0.32
KDM4E B2RXH2 1/20 0.30
LMNA P02545 1/20 0.30
GAA P10253 1/20 0.30
PDK2 Q15119 1/20 0.30
DRD2 P14416 1/20 0.30
RAPGEF4 Q8WZA2 1/20 0.30
GRIA1 P42261 1/20 0.30
CACNG8 Q8WXS5 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27862651 0.98 ALDH1A1 (0.33) ALDH1A1MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL716719 0.83 MEN1 (0.33) ALDH1A1MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL27845453 0.82 MEN1 (0.33) ALDH1A1MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL6382158 0.74 ALDH1A1 (0.40) ALDH1A1MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL815694 0.73 MEN1 (0.33) ALDH1A1MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL30122516 0.73 ALDH1A1 (0.39) ALDH1A1MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL339008 0.72 TP53 (0.43) ALDH1A1MAPTTDP1TP53CYP3A4
SCHEMBL1044722 0.72 MEN1 (0.47) ALDH1A1MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL600285 0.71 PSMB5 (0.35) ALDH1A1MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL31299941 0.71 TP53 (0.41) ALDH1A1MAPTTDP1TP53CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8357765-B2 Process for producing catalyst component for addition polymerization SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2013-01-22 US disclosed
US-8288490-B2 Process for producing catalyst component for addition polymerization SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-10-16 US disclosed
US-20120053306-A1 PROCESS FOR PRODUCING CATALYST COMPONENT FOR ADDITION POLYMERIZATION SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-03-01 US disclosed
US-20120053311-A1 PROCESS FOR PRODUCING CATALYST COMPONENT FOR ADDITION POLYMERIZATION SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-03-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120053306-A1 PROCESS FOR PRODUCING CATALYST COMPONENT FOR ADDITION POLYMERIZATION PPOX, SOD1, AP1M1 ALDH1A1 1442/4885MAPT 467/4885MEN1 2714/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.